Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 in Healthy Participants Who Smoke Cigarettes
Clinical trial NCT03045887 · COMPLETED
Trial details
- NCT number
- NCT03045887
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2017-08-11
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.